Multi-drug therapy of leprosy.
G
G
Ramu
D000818:Animals; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005000:Ethionamide / Q000627:therapeutic use; D005528:Foot / Q000382:microbiology; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy*; D051379:Mice; D009166:Mycobacterium leprae / Q000187:drug effects; D011515:Prothionamide / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D051381:Rats; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use
D007917:Leprostatic Agents; D011718:Pyrazinamide; D011515:Prothionamide; D003622:Dapsone; D002991:Clofazimine; D013828:Thioacetazone; D005000:Ethionamide; D012293:Rifampin